Literature DB >> 1373706

Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.

M Ohno1, A Nishikawa, M Koketsu, H Taga, Y Endo, T Hada, K Higashino, N Taniguchi.   

Abstract

alpha-Fetoproteins (AFPs) were purified from 2 hepatoma cell lines (Hep G2 and HuH-7) and a hepatoblastoma cell line (HuH-6), and the structures of pyridylaminated (PA) derivatives of their sugar chains were analyzed by HPLC. Simultaneously, the activities of alpha 1-6 fucosyltransferase (alpha 1-6FT) and N-acetylglucosaminyltransferase III (GnT-III), IV (GnT-IV) and V (GnT-V) were assayed in these cell lines. For all 3 cell lines the major sugar chain detected was a fucosylated biantennary structure. Hep G2 cells contained a high level of GnT-V, which catalyzes the formation of a tri'-antennary structure, and in fact a substantial percentage of the AFP sugar chains in these cells had the tri'-antennary structure. alpha 1-6FT was also high, and fucosylated tri' structures were detected, which suggests that high activities of transferases affect the AFP sugar chains. In HuH-6 cells, GnT-III, which catalyzes the formation of bisecting GlcNAc, was elevated. Correspondingly, a fucosylated, bisected biantennary structure was found as a major sugar chain. In the HuH-7 cell line, the contents of bisecting GlcNAc and tri' structure were low and neither GnT-III nor GnT-V was elevated. These data indicate that the sugar structures of AFP in these cell lines correlate well with the activities of alpha 1-6 FT, GnT-III and GnT-V.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373706     DOI: 10.1002/ijc.2910510223

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 2.  Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases.

Authors:  N Taniguchi; Y Ihara
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

3.  γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells.

Authors:  Matthew B West; Marie H Hanigan
Journal:  Arch Biochem Biophys       Date:  2010-09-08       Impact factor: 4.013

4.  Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.

Authors:  Anand Mehta; Pamela Norton; Hongyan Liang; Mary Ann Comunale; Mengjun Wang; Lucy Rodemich-Betesh; Alex Koszycki; Katsuhisa Noda; Eiji Miyoshi; Timothy Block
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-06       Impact factor: 4.254

5.  From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises.

Authors:  Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

6.  Glycan-related gene expression signatures in human metastatic hepatocellular carcinoma cells.

Authors:  Xiaonan Kang; Nian Wang; Chen Pei; Lu Sun; Ruixia Sun; Jie Chen; Yinkun Liu
Journal:  Exp Ther Med       Date:  2011-12-23       Impact factor: 2.447

7.  N-linked glycosylation of the liver cancer biomarker GP73.

Authors:  Pamela A Norton; Mary Ann Comunale; Jonathan Krakover; Lucy Rodemich; Natalie Pirog; Anthony D'Amelio; Ramila Philip; Anand S Mehta; Timothy M Block
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

8.  Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.

Authors:  Eun-Young Song; Kyung-Sook Kim; Kyoung-A Kim; Yung-Dai Kim; Dur-Han Kwon; Si-Myung Byun; Hee-Jung Kim; Tae-Wook Chung; Yong-Kyung Choe; Tai-Wha Chung; Cheorl-Ho Kim
Journal:  Glycoconj J       Date:  2002-07       Impact factor: 2.916

9.  Alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV.

Authors:  Yannan Qin; Yaogang Zhong; Tianran Ma; Fei Wu; Haoxiang Wu; Hanjie Yu; Chen Huang; Zheng Li
Journal:  Glycoconj J       Date:  2016-01-30       Impact factor: 2.916

10.  Aberrant glycosylation associated with enzymes as cancer biomarkers.

Authors:  Danni L Meany; Daniel W Chan
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.